Generate a tailored SOP for Dr. Rui Sang. Improve your application with a focused, well-structured draft.
Dr. Rui Sang is a Research Associate at the University of New South Wales (UNSW), specializing in nanoparticle-based technology for cancer treatment and CRISPR-based gene therapy for diagnostic applications. He obtained his Ph.D. from UNSW and has authored 20 peer-reviewed journal articles published in high-impact journals including Nature Communications, eBioMedicine, and Acta Biomaterialia. Dr. Sang's research contributions have secured significant funding, including a total of $160K from grants such as the NICE-UNSW ‘Proof-of-Scale’ Fund and others. He has received multiple awards recognizing his research excellence, including the Chinese Government Award for Outstanding Self-Financed Students Abroad and the Ph.D. Scholarship Top-up Award from the Translational Cancer Research Network. He is also actively involved in the Royal Australian Chemical Institute as Co-Chair of the Women in Chemistry division and has contributed to mentoring undergraduate and PhD students in their research endeavors. Dr. Sang's expertise lies in developing advanced biosensing technologies for sensitive detection of RNA and therapeutic strategies employing nanoparticles for targeted cancer treatment.
University of New South Wales • Sydney, Australia
Conducts research in nanoparticle-based technology for cancer treatment and CRISPR applications.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.